{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:46:48Z","timestamp":1772520408128,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971885"],"award-info":[{"award-number":["81971885"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of china","doi-asserted-by":"crossref","award":["81971888"],"award-info":[{"award-number":["81971888"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Scientific research project of Jiangsu Health Committee","award":["H2018048"],"award-info":[{"award-number":["H2018048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronavirus Disease-2019 (COVID-19) pandemic has become a major health event that endangers people health throughout China and the world. Understanding the factors associated with COVID-19 disease severity could support the early identification of patients with high risk for disease progression, inform prevention and control activities, and potentially reduce mortality. This study aims to describe the characteristics of patients with COVID-19 and factors associated with severe or critically ill presentation in Jiangsu province, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multicentre retrospective cohort study of all individuals with confirmed Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections diagnosed at 24 COVID-19-designated hospitals in Jiangsu province between the 10th January and 15th March 2020. Demographic, clinical, laboratory, and radiological data were collected at hospital admission and data on disease severity were collected during follow-up. Patients were categorised as asymptomatic\/mild\/moderate, and severe\/critically ill according to the worst level of COVID-19 recorded during hospitalisation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 625 patients, 64 (10.2%) were severe\/critically ill and 561 (89.8%) were asymptomatic\/mild\/moderate. All patients were discharged and no patients died. Patients with severe\/critically ill COVID-19 were more likely to be older, to be single onset (i.e. not belong\u00a0to a cluster of cases in a\u00a0family\/community,\u00a0etc.), to have a medical history of hypertension and diabetes; had higher temperature, faster respiratory rates, lower peripheral capillary oxygen saturation (SpO\n                      <jats:sub>2<\/jats:sub>\n                      ), and higher computer tomography (CT) image quadrant scores and pulmonary opacity percentage; had increased C-reactive protein, fibrinogen, and D-dimer on admission; and had lower white blood cells, lymphocyte, and platelet counts and albumin on admission than asymptomatic\/mild\/moderate cases. Multivariable regression showed that odds of being a severe\/critically ill case were associated with age (year) (OR 1.06, 95%CI 1.03\u20131.09), lymphocyte count (10\n                      <jats:sup>9<\/jats:sup>\n                      \/L) (OR 0.25, 95%CI 0.08\u20130.74), and pulmonary opacity in CT (per 5%) on admission (OR 1.31, 95%CI 1.15\u20131.51).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Severe or critically ill patients with COVID-19 is about one-tenths of patients in Jiangsu. Age, lymphocyte count, and pulmonary opacity in CT on admission were associated with risk of severe or critically ill COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05314-x","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T08:04:41Z","timestamp":1596701081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Songqiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E.","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duolao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghong","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1661-3568","authenticated-orcid":false,"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"5314_CR1","unstructured":"World Health Organization. WHO director-General\u2019s opening remarks at the media briefing on COVID-19; 2020. https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed 13 June 2020."},{"key":"5314_CR2","unstructured":"World Health Organization. Coronavirus disease (COVID-19) situation reports. Accessed 13 June 2020. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"issue":"2","key":"5314_CR3","first-page":"145","volume":"41","author":"Chinese Center for Disease Control and Prevention","year":"2020","unstructured":"Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145\u201351.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"5314_CR4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijid.2020.03.031","volume":"93","author":"E Shim","year":"2020","unstructured":"Shim E, Tariq A, Choi W, Lee Y, Chowell G. Transmission potential and severity of COVID-19 in South Korea. Int J Infect Dis. 2020;93:339\u201344.","journal-title":"Int J Infect Dis"},{"key":"5314_CR5","first-page":"44","volume":"2020","author":"COVID-19 National Incident Room Surveillance Team","year":"2018","unstructured":"COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: epidemiology report 17 (fortnightly reporting period ending 24 may 2020). Commun Dis Intell. 2018;2020:44.","journal-title":"Commun Dis Intell"},{"key":"5314_CR6","unstructured":"European Centre for Disease Prevention and Control. Coronavirus disease 2019 (COVID-19) in the EU\/EEA and the UK \u2013 eighth update. Accessed 13 June 2020. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/covid-19-rapid-risk-assessment-coronavirus-disease-2019-eighth-update-8-april-2020.pdf."},{"key":"5314_CR7","doi-asserted-by":"publisher","unstructured":"Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020. https:\/\/doi.org\/10.1001\/jama.2020.4344 Online ahead of print.","DOI":"10.1001\/jama.2020.4344"},{"issue":"18","key":"5314_CR8","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320.","journal-title":"N Engl J Med"},{"issue":"10223","key":"5314_CR9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet."},{"issue":"11","key":"5314_CR10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","journal-title":"JAMA"},{"issue":"5","key":"5314_CR11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475\u201381.","journal-title":"Lancet Respir Med"},{"issue":"24","key":"5314_CR12","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","volume":"382","author":"P Goyal","year":"2020","unstructured":"Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of COVID-19 in new York City. N Engl J Med. 2020;382(24):2372\u20134.","journal-title":"N Engl J Med"},{"key":"5314_CR13","first-page":"200794","volume":"1","author":"AR Mitra","year":"2020","unstructured":"Mitra AR, Fergusson NA, Lloyd-Smith E, et al. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series. CMAJ. 2020;1:200794.","journal-title":"CMAJ"},{"issue":"6","key":"5314_CR14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/RLI.0000000000000672","volume":"55","author":"K Li","year":"2020","unstructured":"Li K, Wu J, Wu F, et al. The clinical and chest CT features associated with severe and critical covid-19 pneumonia. Investig Radiol. 2020;55(6):327\u201331.","journal-title":"Investig Radiol"},{"issue":"1","key":"5314_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-020-00362-2","volume":"19","author":"W Chen","year":"2020","unstructured":"Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob. 2020;19(1):18.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5314_CR16","first-page":"dc200682","volume":"1","author":"F Gao","year":"2020","unstructured":"Gao F, Zheng KI, Wang XB, et al. Obesity is a risk factor for greater COVID-19 severity. Diabetes Care. 2020;1:dc200682.","journal-title":"Diabetes Care"},{"key":"5314_CR17","doi-asserted-by":"publisher","unstructured":"Li J, Li M, Zheng S, et al. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19. Biomark Med. 2020. https:\/\/doi.org\/10.2217\/bmm-2020-0254.","DOI":"10.2217\/bmm-2020-0254"},{"key":"5314_CR18","first-page":"30495","volume":"S0091","author":"X Li","year":"2020","unstructured":"Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;S0091:30495.","journal-title":"J Allergy Clin Immunol"},{"key":"5314_CR19","doi-asserted-by":"publisher","unstructured":"Li Y, Zhao K, Wei H, et al. Dynamic relationship between D-dimer and COVID-19 severity. Br J Haematol. 2020. https:\/\/doi.org\/10.1111\/bjh.16811.","DOI":"10.1111\/bjh.16811"},{"key":"5314_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"G Lippi","year":"2020","unstructured":"Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145\u20138.","journal-title":"Clin Chim Acta"},{"key":"5314_CR21","doi-asserted-by":"publisher","unstructured":"Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020. https:\/\/doi.org\/10.1002\/oby.22831.","DOI":"10.1002\/oby.22831"},{"issue":"21","key":"5314_CR22","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","volume":"382","author":"PK Bhatraju","year":"2020","unstructured":"Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med. 2020;382(21):2012\u201322.","journal-title":"N Engl J Med"},{"key":"5314_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/CM9.0000000000000819","volume":"1","author":"National Health Commission & National Administration of Traditional Chinese Medicine","year":"2020","unstructured":"National Health Commission & National Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7). Chin Med J. 2020;1:133. https:\/\/doi.org\/10.1097\/CM9.0000000000000819.","journal-title":"Chin Med J"},{"issue":"1","key":"5314_CR24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13613-020-00650-2","volume":"10","author":"Q Sun","year":"2020","unstructured":"Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care. 2020;10(1):33.","journal-title":"Ann Intensive Care"},{"issue":"10223","key":"5314_CR25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"10239","key":"5314_CR26","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","volume":"395","author":"MJ Cummings","year":"2020","unstructured":"Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in new York City: a prospective cohort study. Lancet. 2020;395(10239):1763\u201370.","journal-title":"Lancet."},{"issue":"20","key":"5314_CR27","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area. JAMA. 2020;323(20):2052\u20139.","journal-title":"JAMA."},{"key":"5314_CR28","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","volume":"369","author":"CM Petrilli","year":"2020","unstructured":"Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in new York City: prospective cohort study. BMJ. 2020;369:m1966.","journal-title":"BMJ."},{"issue":"15","key":"5314_CR29","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2020.3204","volume":"323","author":"BE Young","year":"2020","unstructured":"Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488\u201394.","journal-title":"JAMA."},{"issue":"13","key":"5314_CR30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","unstructured":"CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, February 12\u2013march 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):382\u20136. https:\/\/doi.org\/10.15585\/mmwr.mm6913e2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"5314_CR31","doi-asserted-by":"crossref","first-page":"m606","DOI":"10.1136\/bmj.m606","volume":"368","author":"XW Xu","year":"2020","unstructured":"Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606.","journal-title":"BMJ"},{"issue":"13","key":"5314_CR32","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239\u201342.","journal-title":"JAMA."},{"key":"5314_CR33","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","volume":"214","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhao Y, Zhang F, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393.","journal-title":"Clin Immunol"},{"issue":"2","key":"5314_CR34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188\u201395.","journal-title":"Blood."},{"key":"5314_CR35","doi-asserted-by":"crossref","unstructured":"Cron R, Behrens EM. Cytokine storm syndrome. 1st ed: Springer International Publishing; 2019.","DOI":"10.1007\/978-3-030-22094-5"},{"issue":"3","key":"5314_CR36","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S2213-2600(20)30071-0","volume":"8","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhou L, Yang Y, Peng W, Wang W, Chen X. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Respir Med. 2020;8(3):e11\u20132.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"5314_CR37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.chest.2017.08.002","volume":"152","author":"K DesPrez","year":"2017","unstructured":"DesPrez K, McNeil JB, Wang C, Bastarache JA, Shaver CM, Ware LB. Oxygenation saturation index predicts clinical outcomes in ARDS. Chest. 2017;152(6):1151\u20138.","journal-title":"Chest."},{"key":"5314_CR38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jcm7010008","volume":"7","author":"WL Chen","year":"2018","unstructured":"Chen WL, Lin WT, Kung SC, Lai CC, Chao CM. The value of oxygenation saturation index in predicting the outcomes of patients with acute respiratory distress syndrome. J Clin Med. 2018;7:8.","journal-title":"J Clin Med"},{"key":"5314_CR39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/v12020135","volume":"12","author":"LE Gralinski","year":"2020","unstructured":"Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020;12:2.","journal-title":"Viruses"},{"key":"5314_CR40","doi-asserted-by":"publisher","unstructured":"Wu J, Li W, Shi X, et al. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19). J Intern Med. 2020. https:\/\/doi.org\/10.1111\/joim.13063.","DOI":"10.1111\/joim.13063"},{"issue":"4","key":"5314_CR41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jmv.25689","volume":"92","author":"W Wang","year":"2020","unstructured":"Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020;92(4):441\u20137.","journal-title":"J Med Virol"},{"issue":"11","key":"5314_CR42","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3201\/eid2111.150764","volume":"21","author":"DR Feikin","year":"2015","unstructured":"Feikin DR, Alraddadi B, Qutub M, et al. Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014. Emerg Infect Dis. 2015;21(11):2029\u201335.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"5314_CR43","first-page":"468","volume":"73","author":"JH Ko","year":"2016","unstructured":"Ko JH, Park GE, Lee JY, et al. Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients. J Inf Secur. 2016;73(5):468\u201375.","journal-title":"J Inf Secur"},{"issue":"11","key":"5314_CR44","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3201\/eid2111.151231","volume":"21","author":"MS Majumder","year":"2015","unstructured":"Majumder MS, Kluberg SA, Mekaru SR, Brownstein JS. Mortality risk factors for middle east respiratory syndrome outbreak, South Korea, 2015. Emerg Infect Dis. 2015;21(11):2088\u201390.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"5314_CR45","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/thorax.58.8.686","volume":"58","author":"JWM Chan","year":"2003","unstructured":"Chan JWM, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003;58(8):686\u20139.","journal-title":"Thorax."},{"issue":"7","key":"5314_CR46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.it.2009.04.007","volume":"30","author":"AC Maue","year":"2009","unstructured":"Maue AC, Yager EJ, Swain SL, Woodland DL, Blackman MA, Haynes L. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol. 2009;30(7):301\u20135.","journal-title":"Trends Immunol"},{"issue":"4","key":"5314_CR47","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425\u201334.","journal-title":"Lancet Infect Dis"},{"key":"5314_CR48","first-page":"1","volume":"1","author":"K Li","year":"2020","unstructured":"Li K, Fang Y, Li W, et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 2020;1:1\u201310.","journal-title":"Eur Radiol"},{"issue":"5","key":"5314_CR49","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620\u20139.","journal-title":"J Clin Invest"},{"key":"5314_CR50","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.","journal-title":"Front Immunol"},{"issue":"3","key":"5314_CR51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.arr.2010.11.002","volume":"10","author":"T Singh","year":"2011","unstructured":"Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev. 2011;10(3):319\u201329.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"5314_CR52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0021-9150(00)00681-X","volume":"156","author":"P Jousilahti","year":"2001","unstructured":"Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T. The association of C-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project. Atherosclerosis. 2001;156(2):451\u20136.","journal-title":"Atherosclerosis."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05314-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T19:15:08Z","timestamp":1628190908000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05314-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5314"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05314-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-23940\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23940\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"19 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the International Council for Harmonisation Guidelines for Good Clinical Practice and the Declaration of Helsinki. All the data in this study were anonymised and provided with administrative permissions from Jiangsu Provincial Health Commission. The Ethics Committee of Zhongda Hospital, Affiliated to Southeast University, approved the study protocols (2020ZDSYLL013\u2013P01 and 2020ZDSYLL019\u2013P01). Patient informed consent was waived due to the retrospective study design.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"584"}}